Evidence map›Paper›PMID 42535234›Full record

ArticleJournal of the anus, rectum and colon2026

Clinicopathological Features and Prognostic Impact of Colorectal Signet-Ring Cell Carcinoma: The Prognostic Impact of Metastatic Lymph Node Histology.

Gen Tsujio, Yusuke Tanaka, Akio Shiomi, Shoichi Manabe, Shunsuke Kasai, Tadahiro Kojima, Takahiro Igaki, Yukihiro Mori, Takuma Oishi

Abstract read
In one paragraph

Article in Journal of the anus, rectum and colon, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Gen TsujioDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Yusuke TanakaDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Akio ShiomiDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Shoichi ManabeDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Shunsuke KasaiDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Tadahiro KojimaDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Takahiro IgakiDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Yukihiro MoriDivision of Colon and Rectal Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
Takuma OishiDepartment of Diagnostic Pathology, Shizuoka Cancer Center, Shizuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Colorectal signet-ring cell carcinoma (SRCC) is a rare histological subtype, accounting for only 0.2-0.9% of all colorectal cancers, and is often diagnosed at an advanced stage with a poor prognosis. However, the clinicopathological and prognostic characteristics of colorectal cancers with SRCC components remain poorly defined. Methods: We retrospectively analyzed 35 patients who underwent surgical resection for primary colorectal cancer containing SRCC components between September 2002 and December 2022 at the Shizuoka Cancer Center. The patients were divided into two groups according to the predominant histological subtype: SRCC (n = 7) and adenocarcinoma with a signet-ring cell component (AC with SRC; n = 28). Clinicopathological features and survival outcomes were compared between the groups. Among the patients with lymph node metastasis, survival was compared according to the presence of SRCC in the metastatic lymph nodes (LNM SRCC+, n = 13; LNM SRCC-, n = 13). Results: Of the 35 patients, 7 were classified as having SRCC and 28 as having AC with SRC. Most cases were T3 or deeper tumors (85.7%), with frequent lymphatic invasion (82.9%) and lymph node metastasis (74.3%). The prognosis did not differ between SRCC and AC with SRC, whereas the presence of SRCC in metastatic lymph nodes was associated with significantly poorer overall and relapse-free survival (P = 0.048 and 0.012, respectively). Conclusions: Colorectal cancers with SRCC components are typically advanced and aggressive. The presence of SRCC components confers a poor prognosis, and SRCC in metastatic lymph nodes represents an important adverse prognostic indicator.

Indexed as

colorectal cancerlymph node metastasissignet-ring cell carcinoma

Identifiers

PMID42535234
PMCPMC13423498

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.